Between 2014 and 2017, the company allegedly knowingly caused colorectal and general surgeons to use incorrect codes to obtain inflated reimbursements from Medicare and state Medicaid programs for the use of THD’s hemorrhoid removal system, according to a Sept. 6 news release from the Justice Department.
The removal system was sold to physicians for use in transanal hemorrhoidal dearterialization, according to the release, and THD required physicians to bill for the procedure using a temporary code for new and emerging procedures, which are often denied.
To avoid denials, THD encouraged colorectal and general surgeons to improperly bill Medicare and Medicaid programs using the temporary code plus an additional CPT code or to bill for other CPT codes.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
